Coghlan JG - Search Results

1

Connective tissue associated pulmonary arterial hypertension.

Coghlan JG, Handler C. Coghlan JG, et al. Lupus. 2006;15(3):138-42. doi: 10.1191/0961203306lu2280rr. Lupus. 2006. PMID: 16634366 Review.

2

Soluble thrombomodulin concentration is raised in scleroderma associated pulmonary hypertension.

Stratton RJ, Pompon L, Coghlan JG, Pearson JD, Black CM. Stratton RJ, et al. Among authors: coghlan jg. Ann Rheum Dis. 2000 Feb;59(2):132-4. doi: 10.1136/ard.59.2.132. Ann Rheum Dis. 2000. PMID: 10666169 Free PMC article.

3

Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival.

MacGregor AJ, Canavan R, Knight C, Denton CP, Davar J, Coghlan J, Black CM. MacGregor AJ, et al. Rheumatology (Oxford). 2001 Apr;40(4):453-9. doi: 10.1093/rheumatology/40.4.453. Rheumatology (Oxford). 2001. PMID: 11312386

4

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG. Mukerjee D, et al. Among authors: coghlan jg. Ann Rheum Dis. 2003 Nov;62(11):1088-93. doi: 10.1136/ard.62.11.1088. Ann Rheum Dis. 2003. PMID: 14583573 Free PMC article.

5

Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis.

Mukerjee D, St George D, Knight C, Davar J, Wells AU, Du Bois RM, Black CM, Coghlan JG. Mukerjee D, et al. Among authors: coghlan jg. Rheumatology (Oxford). 2004 Apr;43(4):461-6. doi: 10.1093/rheumatology/keh067. Epub 2004 Jan 6. Rheumatology (Oxford). 2004. PMID: 15024134

6

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

Williams MH, Das C, Handler CE, Akram MR, Davar J, Denton CP, Smith CJ, Black CM, Coghlan JG. Williams MH, et al. Among authors: coghlan jg. Heart. 2006 Jul;92(7):926-32. doi: 10.1136/hrt.2005.069484. Epub 2005 Dec 9. Heart. 2006. PMID: 16339813 Free PMC article.

7

Angiographically proven coronary artery disease in scleroderma.

Akram MR, Handler CE, Williams M, Carulli MT, Andron M, Black CM, Denton CP, Coghlan JG. Akram MR, et al. Among authors: coghlan jg. Rheumatology (Oxford). 2006 Nov;45(11):1395-8. doi: 10.1093/rheumatology/kel120. Epub 2006 Apr 10. Rheumatology (Oxford). 2006. PMID: 16606654

8

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.

Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG. Williams MH, et al. Among authors: coghlan jg. Eur Heart J. 2006 Jun;27(12):1485-94. doi: 10.1093/eurheartj/ehi891. Epub 2006 Apr 27. Eur Heart J. 2006. PMID: 16682379

9

Cardiac assessment of patients for haematopoietic stem cell transplantation.

Coghlan JG, Handler CE, Kottaridis PD. Coghlan JG, et al. Best Pract Res Clin Haematol. 2007 Jun;20(2):247-63. doi: 10.1016/j.beha.2006.09.005. Best Pract Res Clin Haematol. 2007. PMID: 17448960 Review.

10

Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?

Carulli MT, Handler C, Coghlan JG, Black CM, Denton CP. Carulli MT, et al. Among authors: coghlan jg. Ann Rheum Dis. 2008 Jan;67(1):105-9. doi: 10.1136/ard.2006.067967. Epub 2007 Jun 29. Ann Rheum Dis. 2008. PMID: 17604287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters